Xin‐Hai Ni

999 total citations
46 papers, 686 citations indexed

About

Xin‐Hai Ni is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Xin‐Hai Ni has authored 46 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 24 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Xin‐Hai Ni's work include Pulmonary Hypertension Research and Treatments (34 papers), Heart Failure Treatment and Management (9 papers) and Cardiovascular Issues in Pregnancy (8 papers). Xin‐Hai Ni is often cited by papers focused on Pulmonary Hypertension Research and Treatments (34 papers), Heart Failure Treatment and Management (9 papers) and Cardiovascular Issues in Pregnancy (8 papers). Xin‐Hai Ni collaborates with scholars based in China, United Kingdom and Australia. Xin‐Hai Ni's co-authors include Jianguo He, Changming Xiong, Zhihong Liu, Qing Gu, Zhihui Zhao, Tao Yang, Qin Luo, Yaguo Zheng, Zhihong Liu and Changming Xiong and has published in prestigious journals such as European Respiratory Journal, Journal of the American Heart Association and Respiratory Medicine.

In The Last Decade

Xin‐Hai Ni

46 papers receiving 676 citations

Peers

Xin‐Hai Ni
Martin Doelberg Switzerland
Mona Selej United States
Christine Archer‐Chicko United States
Chika Uotani Japan
Beau M. Hawkins United States
Hikmet Al‐Hiti Czechia
Andjela Kusic‐Pajic Switzerland
Edit Nagy Sweden
Ronald J. Raymond United States
Delphine Natali France
Martin Doelberg Switzerland
Xin‐Hai Ni
Citations per year, relative to Xin‐Hai Ni Xin‐Hai Ni (= 1×) peers Martin Doelberg

Countries citing papers authored by Xin‐Hai Ni

Since Specialization
Citations

This map shows the geographic impact of Xin‐Hai Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin‐Hai Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin‐Hai Ni more than expected).

Fields of papers citing papers by Xin‐Hai Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin‐Hai Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin‐Hai Ni. The network helps show where Xin‐Hai Ni may publish in the future.

Co-authorship network of co-authors of Xin‐Hai Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Xin‐Hai Ni. A scholar is included among the top collaborators of Xin‐Hai Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin‐Hai Ni. Xin‐Hai Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Qi, Yi Tang, Zhihong Liu, et al.. (2020). Serum human epididymis protein 4 level as a predictor of clinical worsening in idiopathic pulmonary arterial hypertension: a pilot study. BMC Cardiovascular Disorders. 20(1). 175–175. 7 indexed citations
2.
Li, Wen, Tao Yang, Changming Xiong, et al.. (2019). Association between splenectomy and portal hypertension in the development of pulmonary hypertension. Pulmonary Circulation. 10(1). 1–9. 4 indexed citations
3.
Tang, Yi, Lei Yao, Zhihong Liu, et al.. (2018). Peak circulatory power is a strong prognostic factor in patients with idiopathic pulmonary arterial hypertension. Respiratory Medicine. 135. 29–34. 10 indexed citations
4.
5.
Cheng, Xiaoling, Jianguo He, Zhihong Liu, et al.. (2016). The Value of the Electrocardiogram for Evaluating Prognosis in Patients with Idiopathic Pulmonary Arterial Hypertension. Lung. 195(1). 139–146. 16 indexed citations
6.
Ni, Xin‐Hai, et al.. (2015). High levels of serum lactate dehydrogenase correlate with the severity and mortality of idiopathic pulmonary arterial hypertension. Experimental and Therapeutic Medicine. 9(6). 2109–2113. 35 indexed citations
7.
Li, Wen, Lei Wang, Changming Xiong, et al.. (2015). The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension. Clinical Nuclear Medicine. 40(11). 859–863. 15 indexed citations
8.
Yang, Tao, Lei Wang, Changming Xiong, et al.. (2014). The Ratio of 18F-FDG Activity Uptake Between the Right and Left Ventricle in Patients With Pulmonary Hypertension Correlates With the Right Ventricular Function. Clinical Nuclear Medicine. 39(5). 426–430. 30 indexed citations
9.
10.
Sun, Yunjuan, Tao Yang, Weijie Zeng, et al.. (2013). Impact of Sildenafil on Survival of Patients With Eisenmenger Syndrome. The Journal of Clinical Pharmacology. 53(6). 611–618. 25 indexed citations
11.
Zeng, Weijie, Changming Xiong, Lan Zhao, et al.. (2012). Atorvastatin in Pulmonary Arterial Hypertension (APATH) study. European Respiratory Journal. 40(1). 67–74. 50 indexed citations
12.
13.
Sun, Yunjuan, Changming Xiong, Guangliang Shan, et al.. (2012). Inhaled Low‐Dose Iloprost for Pulmonary Hypertension: A Prospective, Multicenter, Open‐Label Study. Clinical Cardiology. 35(6). 365–370. 8 indexed citations
14.
Zeng, Weijie, Changming Xiong, Guangliang Shan, et al.. (2011). The Efficacy and Safety of Sildenafil in Patients With Pulmonary Arterial Hypertension Associated With the Different Types of Congenital Heart Disease. Clinical Cardiology. 34(8). 513–518. 26 indexed citations
15.
Ni, Xin‐Hai, Xincao Tao, Jianqiang Zhang, et al.. (2009). [The prognosis study of 108 idiopathic pulmonary arterial hypertension patients].. PubMed. 37(8). 708–11. 1 indexed citations
16.
Fang, Wei, et al.. (2009). Comparison of Lung Scintigraphy With Multi-Slice Spiral Computed Tomography in the Diagnosis of Pulmonary Embolism. Clinical Nuclear Medicine. 34(7). 424–427. 17 indexed citations
17.
18.
Zhang, Hongliang, Qin Luo, Zhihong Liu, et al.. (2009). Heart rate-corrected QT interval and QT dispersion in patients with pulmonary hypertension. Wiener klinische Wochenschrift. 121(9-10). 330–333. 36 indexed citations
19.
Zhang, Jianqiang, Ying Zhang, Ning Li, et al.. (2009). Potential diagnostic biomarkers in serum of idiopathic pulmonary arterial hypertension. Respiratory Medicine. 103(12). 1801–1806. 30 indexed citations
20.
Xiong, Changming, Xian-sheng Cheng, Zhihong Liu, et al.. (2004). [Pulmonary artery sarcoma misdiagnosed as pulmonary thromboembolism: report of 3 cases and literature review].. PubMed. 27(11). 737–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Doelberg Breakdown of academic impact, for papers by Mona Selej Breakdown of academic impact, for papers by Christine Archer‐Chicko Breakdown of academic impact, for papers by Chika Uotani Breakdown of academic impact, for papers by Beau M. Hawkins Breakdown of academic impact, for papers by Hikmet Al‐Hiti Breakdown of academic impact, for papers by Andjela Kusic‐Pajic Breakdown of academic impact, for papers by Edit Nagy Breakdown of academic impact, for papers by Ronald J. Raymond Breakdown of academic impact, for papers by Delphine Natali
Rankless by CCL
2026